viernes, 23 de agosto de 2024

Drug Trials Snapshots: PIASKY (crovalimab-akkz)

PIASKY is a prescription drug that is a complement C5 inhibitor used to treat adult and pediatric patients 13 years and older with a disease called paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg. PNH is a serious, life-threatening disease which is characterized by destruction of red blood cells (hemolysis), blood clots (thrombosis), and bone marrow dysfunction due to the overactivation of the complement system, a part of the body’s immune system. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-piasky

No hay comentarios:

Publicar un comentario